Showing results (21-30 of 75) with videos related to
Sort By:
Pageof 8
European Journal of Medicinal Chemistry|February 4, 2016
New quinoline derivatives as nicotinic receptor modulatorsDina Manetti, Cristina Bellucci, Silvia Dei, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agentElisabetta Martini, Carla Ghelardini, Carlo Bertucci, et al.Bioorganic & Medicinal Chemistry|December 31, 2003
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugsSerena Scapecchi, Elisabetta Martini, Dina Manetti, et al.European Journal of Medicinal Chemistry|January 24, 2017
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacyElisabetta Teodori, Silvia Dei, Marcella Coronnello, et al.Bioorganic & Medicinal Chemistry|November 6, 2007
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancersElisabetta Martini, Carla Ghelardini, Silvia Dei, et al.Journal of Medicinal Chemistry|January 29, 2010
Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitorsCecilia Martelli, Marcella Coronnello, Silvia Dei, et al.Journal of Medicinal Chemistry|January 30, 2007
Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitorsElisabetta Teodori, Cecilia Martelli, Milena Salerno, et al.Journal of Medicinal Chemistry|November 11, 2005
Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil modelsElisabetta Teodori, Silvia Dei, Arlette Garnier-Suillerot, et al.Molecules (Basel, Switzerland)|April 16, 2020
Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer CellsElisabetta Teodori, Laura Braconi, Silvia Bua, et al.Molecular Biosystems|April 28, 2009
Receptor-independent modulation of reconstituted Galpha(i) protein mediated by liposomesPaola Luciani, Debora Berti, Martina Fortini, et al.Pageof 8